Literature Information
| DOI | 10.1016/j.cell.2026.01.003 |
|---|---|
| PMID | 41713417 |
| Journal | Cell |
| Impact Factor | 42.5 |
| JCR Quartile | Q1 |
| Publication Year | 2026 |
| Times Cited | 0 |
| Keywords | atom-level interaction, drug design, foundation model, generative model, molecular docking |
| Literature Type | Journal Article |
| ISSN | 0092-8674 |
| Authors | Xingang Peng, Ruihan Guo, Fenglin Guo, Ziyi Wang, Jiayu Sun, Jiaqi Guan, Yinjun Jia, Yan Xu, Yanwen Huang, Muhan Zhang, Jian Peng, Xinquan Wang, Chuanhui Han, Zihua Wang, Jianzhu Ma |
TL;DR
PocketXMol is an innovative atom-level model designed for generative tasks related to protein pocket interactions, enabling structure prediction and small molecule and peptide design without the need for task-specific fine-tuning. Demonstrating superior performance on multiple benchmarks and successful applications in designing effective caspase-9 inhibitors and PD-L1-binding peptides, PocketXMol offers a versatile platform for advancing AI-driven drug discovery and therapeutic development.
Search for more papers on MaltSci.com
atom-level interaction · drug design · foundation model · generative model · molecular docking
Abstract
We present PocketXMol, an atom-level model that unifies generative tasks related to protein pocket interactions. Using atomic prompts as task specifications, PocketXMol supports various molecular tasks, including structure prediction and de novo design of small molecules and peptides, without task-specific fine-tuning. PocketXMol achieved strong performance on 11 of 13 computational benchmarks and remained competitive on the remaining two, outperforming 55 baseline models. We applied PocketXMol to design caspase-9-inhibiting small molecules, achieving efficacy comparable with commercial pan-caspase inhibitors. We also adopted PocketXMol to generate PD-L1-binding peptides, resulting in a success rate that largely exceeds library screening. Three representative peptides underwent further experiments, which validated their cellular specificity and confirmed their potential for molecular probing and therapeutics. PocketXMol provides a general platform for AI-aided drug discovery and enables a wide range of future applications.
MaltSci.com AI Research Service
Primary Questions Addressed
- How does PocketXMol compare to traditional molecular modeling approaches in terms of accuracy and efficiency?
- What specific atomic interactions are most critical for the performance of PocketXMol in generating molecular structures?
- Can PocketXMol be adapted for other types of molecular interactions beyond protein pocket interactions?
- What limitations does PocketXMol have when applied to more complex biological systems or larger molecules?
- How can the success rate of PD-L1-binding peptides generated by PocketXMol be further improved in future studies?
Key Findings
Research Background and Purpose
The study introduces PocketXMol, an innovative atom-level model designed to enhance generative tasks related to protein pocket interactions. The primary objective is to create a versatile tool that can perform various molecular tasks—such as structure prediction and de novo design of small molecules and peptides—without the need for task-specific fine-tuning.
Main Methods/Materials/Experimental Design
PocketXMol utilizes atomic prompts as task specifications, enabling it to tackle multiple molecular tasks efficiently. The research methodology can be outlined as follows:
Model Architecture: PocketXMol is built on a generative model framework that operates at the atomic level, allowing for precise interactions with protein pockets.
Tasks Supported: The model supports tasks including:
- Structure prediction of proteins and small molecules.
- De novo design of small molecules and peptides.
Benchmarking: The model’s performance was evaluated against 13 computational benchmarks, where it demonstrated strong performance on 11 and remained competitive on the other two, surpassing 55 baseline models.
Applications:
- Design of Caspase-9 Inhibitors: PocketXMol was employed to design small molecules that inhibit caspase-9, achieving efficacy comparable to existing commercial pan-caspase inhibitors.
- Generation of PD-L1-Binding Peptides: The model was also utilized to generate peptides that bind to PD-L1, with a success rate significantly exceeding traditional library screening methods.
The experimental workflow can be visualized as follows:
Key Results and Findings
- PocketXMol achieved strong performance metrics across various tasks, demonstrating its versatility and robustness.
- In the design of caspase-9 inhibitors, the small molecules generated exhibited efficacy on par with established inhibitors, indicating the model’s potential in drug development.
- The generated PD-L1-binding peptides showed a high success rate, leading to the selection of three representative peptides for further validation.
- Experimental validation confirmed the cellular specificity of these peptides, showcasing their potential for therapeutic applications.
Main Conclusion/Significance/Innovation
PocketXMol represents a significant advancement in AI-aided drug discovery, providing a unified platform for tackling a range of molecular design challenges. Its ability to operate without task-specific fine-tuning makes it a powerful tool for researchers in the field of medicinal chemistry and molecular biology. The model’s success in designing effective inhibitors and peptides suggests it could greatly enhance the efficiency of drug discovery processes.
Research Limitations and Future Directions
While PocketXMol has demonstrated impressive capabilities, several limitations and future research directions have been identified:
- Limitations: The study primarily focused on specific targets (caspase-9 and PD-L1). Further validation across a broader range of targets is necessary to fully establish the model’s generalizability.
- Future Directions:
- Expanding the model’s application to additional therapeutic targets and molecular types.
- Enhancing the model’s training dataset to improve its predictive capabilities and accuracy.
- Exploring integration with other computational methods to refine drug discovery processes further.
Overall, PocketXMol has the potential to revolutionize the landscape of molecular design and therapeutic development, paving the way for future innovations in the field.
© 2025 MaltSci - We reshape scientific research with AI technology